← Back to Search

Vitamin

Vitamin D for COVID-19 Prevention

N/A
Waitlist Available
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subjects are 18 years or older
Be older than 18 years old
Must not have
Report a history of hyperparathyroidism
Report a history of kidney stones (1 in past year or 2 in lifetime)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 9 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing if different doses of vitamin D can help prevent people from getting COVID-19 or make the illness less severe.

Who is the study for?
This trial is for adults over 18 living or working in the Chicagoland area who are interested in using vitamin D to prevent COVID-19. They must be willing to take daily doses of vitamin D, attend quarterly blood tests, and complete surveys throughout the 9-month study. People with certain medical conditions like hyperparathyroidism, kidney stones, or high calcium levels can't join.
What is being tested?
The study aims to see if different doses of Vitamin D (low at 400 IU/day vs. moderate at 4,000 IU/day vs. high at 10,000 IU/day) affect the risk of getting COVID-19 among participants from Chicago communities over a period of nine months.
What are the potential side effects?
Potential side effects may include elevated calcium levels which could lead to kidney stones or digestive issues; however, these risks are generally low and will be monitored through regular blood tests during the trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a history of hyperparathyroidism.
Select...
I have had kidney stones before (1 in the last year or 2 ever).
Select...
I have a history of chronic kidney disease.
Select...
I have a history of falling more often than usual.
Select...
I have had surgery to help with weight loss or have a condition that affects how my body absorbs food.
Select...
I have a history of sarcoidosis.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~9 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 9 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Inverse PCR
Secondary study objectives
SARS-CoV-2 antibody seroconversion confirmed by a COVID-19 antibody test
Other study objectives
Death following COVID-19
Hospitalization following COVID-19
ICU stay following COVID-19
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Active Control
Group I: Low Dose Vitamin DActive Control1 Intervention
Subjects in this arm will be randomized to receive low dose vitamin D therapy (oral, 400 IU/day) for 9 continuous months.
Group II: Medium Dose Vitamin DActive Control1 Intervention
Subjects in this arm will be randomized to receive low dose vitamin D therapy (oral, 4,000 IU/day) for 9 continuous months.
Group III: High Dose Vitamin DActive Control1 Intervention
Subjects in this arm will be randomized to receive low dose vitamin D therapy (oral, 10,000 IU/day) for 9 continuous months.

Find a Location

Who is running the clinical trial?

University of ChicagoLead Sponsor
1,056 Previous Clinical Trials
758,909 Total Patients Enrolled
12 Trials studying COVID-19
34,552 Patients Enrolled for COVID-19
Rush University Medical CenterOTHER
436 Previous Clinical Trials
247,364 Total Patients Enrolled
7 Trials studying COVID-19
12,199 Patients Enrolled for COVID-19

Media Library

Vitamin D3 (Vitamin) Clinical Trial Eligibility Overview. Trial Name: NCT04868903 — N/A
COVID-19 Research Study Groups: Low Dose Vitamin D, Medium Dose Vitamin D, High Dose Vitamin D
COVID-19 Clinical Trial 2023: Vitamin D3 Highlights & Side Effects. Trial Name: NCT04868903 — N/A
Vitamin D3 (Vitamin) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04868903 — N/A
~407 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top